02329 GLORY HEALTH
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 1.03X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 113.1% | Net Margin | N/A |
Total Debt/Equity | 229.5% | Return on Equity | N/A |
Price/Book | 0.08X | Return on Assets | N/A |
(HKD 0.198) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -1,319.20 | -621.61 | -1,023.41 | 279.27 | 117.18 |
---|---|---|---|---|---|
Net Profit Growth (%) | -112.2 | +39.3 | -466.5 | +138.3 | -87.8 |
Earnings Per Share (HKD) | -0.297 | -0.14 | -0.23 | 0.063 | 0.026 |
Earnings Per Share Growth (%) | -112.2 | +39.3 | -466.7 | +137.9 | -87.8 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | 3.15 | 7.50 |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 2.376 | 2.770 | 2.960 | 3.497 | 3.336 |
Auditors' Opinion | Qualified | Qualified | Qualified | Unqualified # | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 2,705 | 2,506 | +7.9 | 3,905 |
Operating Result | -1,335 | -752.168 | +77.5 | -1,135 |
Associates | -69.929 | -72.57 | -3.6 | 42.027 |
Profit Before Taxation | -1,436 | -678.62 | +111.6 | -1,090 |
Taxation | -20.805 | -85.117 | -75.6 | -95.051 |
Profit /( Loss) After Taxation | -1,416 | -593.503 | +138.6 | -995.293 |
Minority Interests | -175.074 | -29.532 | +492.8 | -82.511 |
Net Profit | -1,240 | -563.971 | +119.9 | -912.782 |
Earnings Per Share () | -0.2968 | -0.1399 | +112.2 | -0.2303 |
Announcement Date | 2025-03-31 | 2024-03-28 | NA | 2023-04-02 |
* Annualised
Last Update Time: 2025-07-22 21:40:25